Nuveen Asset Management LLC Buys 255,273 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Nuveen Asset Management LLC lifted its stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 110.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 485,587 shares of the company's stock after buying an additional 255,273 shares during the period. Nuveen Asset Management LLC owned about 0.57% of Pediatrix Medical Group worth $6,371,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Parkside Financial Bank & Trust raised its position in Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock worth $51,000 after purchasing an additional 1,040 shares in the last quarter. Nomura Asset Management Co. Ltd. raised its position in Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after purchasing an additional 1,220 shares in the last quarter. AlphaQuest LLC raised its position in Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after purchasing an additional 2,012 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Pediatrix Medical Group by 6.1% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 49,002 shares of the company's stock worth $643,000 after purchasing an additional 2,801 shares in the last quarter. Finally, Illinois Municipal Retirement Fund raised its position in Pediatrix Medical Group by 7.8% in the fourth quarter. Illinois Municipal Retirement Fund now owns 47,409 shares of the company's stock worth $622,000 after purchasing an additional 3,411 shares in the last quarter. Institutional investors and hedge funds own 97.71% of the company's stock.

Analysts Set New Price Targets

Several analysts have recently weighed in on MD shares. Truist Financial dropped their price objective on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a report on Friday, April 11th. Macquarie raised their price objective on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a report on Thursday, May 8th. Finally, UBS Group dropped their price objective on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a report on Monday, May 12th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $16.67.

Pediatrix Medical Group Stock Up 0.9%

MD stock traded up $0.12 during midday trading on Wednesday, hitting $13.92. The company's stock had a trading volume of 545,862 shares, compared to its average volume of 843,713. The stock has a market capitalization of $1.20 billion, a P/E ratio of -11.60, a PEG ratio of 1.74 and a beta of 1.26. The company's fifty day moving average price is $13.67 and its 200 day moving average price is $14.02. Pediatrix Medical Group, Inc. has a twelve month low of $6.62 and a twelve month high of $17.67. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.08. The company had revenue of $458.36 million for the quarter, compared to analyst estimates of $451.44 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. Pediatrix Medical Group's revenue for the quarter was down 7.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.20 EPS. As a group, equities research analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.